- Home
- ZLAB vs UA Comparison
ZLAB vs UA Comparison
Compare ZLAB & UA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | UA |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZLAB | UA |
|---|---|---|
| Price | $18.57 | $5.61 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $53.52 | N/A |
| AVG Volume (30 Days) | 890.5K | ★ 6.8M |
| Earning Date | 02-26-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $441,629,000.00 | ★ $5,049,070,000.00 |
| Revenue This Year | $26.16 | N/A |
| Revenue Next Year | $30.62 | $1.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | N/A |
| 52 Week Low | $16.82 | $3.95 |
| 52 Week High | $44.34 | $7.85 |
Technical Indicators
Market Signals| Indicator | ZLAB | UA |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 70.73 |
| Support Level | $18.40 | $5.20 |
| Resistance Level | $19.83 | $5.60 |
| Average True Range (ATR) | 0.56 | 0.28 |
| MACD | 0.26 | 0.05 |
| Stochastic Oscillator | 53.02 | 86.24 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About UA Under Armour Inc. Class C
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.